Characterization and monitoring by droplet digital PCR of a novel BCR-ABL1 fusion transcript in a patient with chronic myeloid leukemia
Early Prediction of Subsequent Molecular Response to Nilotinib in Patients with Chronic Myeloid Leukemia: Comparison of the Quantification of BCR-ABL1 Ratios Using ABL1 or GUSB Control Genes - ScienceDirect
Response and Resistance to BCR-ABL1-Targeted Therapies - ScienceDirect
Persistence of LSCs: BCR-ABL1 kinase-dependent and -independent pathways. | Download Scientific Diagram
Cancers | Free Full-Text | Resistance to Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia—From Molecular Mechanisms to Clinical Relevance
Change in BCR-ABL1 IS over time based on achievement of BCR-ABL1 IS 10%... | Download Scientific Diagram
IJMS | Free Full-Text | Genetic Biomarkers in Chronic Myeloid Leukemia: What Have We Learned So Far?
Major Molecular Response Achievement in CML Patients Can Be Predicted by BCR -ABL1/ABL1 or BCR-ABL1/GUS Ratio at an Earlier Time Point of Follow-Up than Currently Recommended | PLOS ONE
Low prevalence of the BCR–ABL1 fusion gene in a normal population in southern Sarawak | SpringerLink
Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia | NEJM
Measurable residual disease in chronic myeloid leukemia | Haematologica
Is the BCR-ABL/GUSB transcript level at diagnosis an early predictive marker for chronic myeloid leukemia patients treated with imatinib? – ScienceOpen
Myeloproliferative neoplasms with concurrent BCR–ABL1 translocation and JAK2 V617F mutation: a multi-institutional study from the bone marrow pathology group | Modern Pathology
BCR/ABL1–like acute lymphoblastic leukemia: How to diagnose and treat? - Chiaretti - 2019 - Cancer - Wiley Online Library
Pharmaceutics | Free Full-Text | BCR-ABL1 Tyrosine Kinase Complex Signaling Transduction: Challenges to Overcome Resistance in Chronic Myeloid Leukemia
IVD Antibody Development Services for BCR-ABL Marker - Creative Biolabs
Precision Medicine in BCR-ABL1 Negative Myeloproliferative Neoplasms | Published in healthbook TIMES Oncology Hematology
Persistence of LSCs: BCR-ABL1 kinase-dependent and -independent pathways. | Download Scientific Diagram
Measurable residual disease in chronic myeloid leukemia | Haematologica
Analysis of chronic myeloid leukaemia during deep molecular response by genomic PCR: a traffic light stratification model with impact on treatment-free remission | Leukemia
Cancers | Free Full-Text | Standardization of BCR-ABL1 p210 Monitoring: From Nested to Digital PCR
BCR/ABL1–like acute lymphoblastic leukemia: How to diagnose and treat? - Chiaretti - 2019 - Cancer - Wiley Online Library
Response and Resistance to BCR-ABL1-Targeted Therapies - ScienceDirect
Multiplex PCR of BCR-ABL1 transcript variants in CML patients... | Download Scientific Diagram
Flow Cytometric Immunobead Assay for Detection of BCR-ABL1 Fusion Proteins in Chronic Myleoid Leukemia: Comparison with FISH and PCR Techniques | PLOS ONE
Characterization and monitoring by droplet digital PCR of a novel BCR-ABL1 fusion transcript in a patient with chronic myeloid leukemia
Frontiers | Genomic Copy Number Variants in CML Patients With the Philadelphia Chromosome (Ph+): An Update
The role of BCR-ABL1 in the genomic instability. High levels of... | Download Scientific Diagram
